urea has been researched along with Myeloproliferative Disorders in 2 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, MA | 1 |
| Curry, JE | 1 |
| Barber, K | 1 |
| Beer, PA | 1 |
| Graham, B | 1 |
| Lyons, JF | 1 |
| Richardson, CJ | 1 |
| Scott, MA | 1 |
| Smyth, T | 1 |
| Squires, MS | 1 |
| Thompson, NT | 1 |
| Green, AR | 1 |
| Wallis, NG | 1 |
| Humberstone, DA | 1 |
| Shaw, JH | 1 |
2 other studies available for urea and Myeloproliferative Disorders
| Article | Year |
|---|---|
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders.
Topics: Animals; Antineoplastic Agents; Aurora Kinase B; Aurora Kinases; Benzimidazoles; Cell Cycle; Cell Pr | 2010 |
Metabolism in hematologic malignancy.
Topics: Adult; Aged; Calorimetry; Energy Metabolism; Female; Glucose; Humans; Leukemia; Lymphoma; Male; Midd | 1988 |